These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 8383804

  • 1. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells.
    Carter BD, Medzihradsky F.
    Mol Pharmacol; 1993 Mar; 43(3):465-73. PubMed ID: 8383804
    [Abstract] [Full Text] [Related]

  • 2. Reversible modulation of opioid receptor binding in intact neural cells by endogenous guanosine triphosphate.
    Yabaluri N, Medzihradsky F.
    Mol Pharmacol; 1995 Oct; 48(4):690-5. PubMed ID: 7476895
    [Abstract] [Full Text] [Related]

  • 3. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
    Costa T, Klinz FJ, Vachon L, Herz A.
    Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
    [Abstract] [Full Text] [Related]

  • 4. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ, Traynor JR.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [Abstract] [Full Text] [Related]

  • 5. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL, Tsai AW, Law PY.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [Abstract] [Full Text] [Related]

  • 6. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY, Bergsbaken C.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [Abstract] [Full Text] [Related]

  • 7. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus.
    Duman RS, Tallman JF, Nestler EJ.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1033-9. PubMed ID: 2843624
    [Abstract] [Full Text] [Related]

  • 8. Differential G-protein activation by alkaloid and peptide opioid agonists in the human neuroblastoma cell line SK-N-BE.
    Allouche S, Polastron J, Hasbi A, Homburger V, Jauzac P.
    Biochem J; 1999 Aug 15; 342 ( Pt 1)(Pt 1):71-8. PubMed ID: 10432302
    [Abstract] [Full Text] [Related]

  • 9. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
    Baumhaker Y, Gafni M, Keren O, Sarne Y.
    Mol Pharmacol; 1993 Aug 15; 44(2):461-7. PubMed ID: 8394999
    [Abstract] [Full Text] [Related]

  • 10. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM, Mishra RK.
    Mol Pharmacol; 1987 Jul 15; 32(1):109-18. PubMed ID: 3037297
    [Abstract] [Full Text] [Related]

  • 11. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR, Fleming LM, Selley DE, McNutt RW, Chang KJ.
    Mol Pharmacol; 1993 Oct 15; 44(4):827-34. PubMed ID: 8232233
    [Abstract] [Full Text] [Related]

  • 12. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY, Hom DS, Loh HH.
    Mol Pharmacol; 1983 Nov 15; 24(3):413-24. PubMed ID: 6314114
    [Abstract] [Full Text] [Related]

  • 13. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
    Zadina JE, Chang SL, Ge LJ, Kastin AJ.
    J Pharmacol Exp Ther; 1993 Apr 15; 265(1):254-62. PubMed ID: 8097244
    [Abstract] [Full Text] [Related]

  • 14. Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling.
    Szücs M, Boda K, Gintzler AR.
    J Pharmacol Exp Ther; 2004 Jul 15; 310(1):256-62. PubMed ID: 14996951
    [Abstract] [Full Text] [Related]

  • 15. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE, Breivogel CS, Childers SR.
    Mol Pharmacol; 1993 Oct 15; 44(4):731-41. PubMed ID: 8232223
    [Abstract] [Full Text] [Related]

  • 16. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain.
    Carter BD, Medzihradsky F.
    Proc Natl Acad Sci U S A; 1993 May 01; 90(9):4062-6. PubMed ID: 8097884
    [Abstract] [Full Text] [Related]

  • 17. Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy.
    Remmers AE, Clark MJ, Liu XY, Medzihradsky F.
    J Pharmacol Exp Ther; 1998 Nov 01; 287(2):625-32. PubMed ID: 9808689
    [Abstract] [Full Text] [Related]

  • 18. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
    Chakrabarti S, Yang W, Law PY, Loh HH.
    Mol Pharmacol; 1997 Jul 01; 52(1):105-13. PubMed ID: 9224819
    [Abstract] [Full Text] [Related]

  • 19. Mu-opioid receptor inhibition of calcium current: development of homologous tolerance in single SH-SY5Y cells after chronic exposure to morphine in vitro.
    Kennedy C, Henderson G.
    Mol Pharmacol; 1991 Dec 01; 40(6):1000-5. PubMed ID: 1661836
    [Abstract] [Full Text] [Related]

  • 20. Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Galphai2 in neuroblastoma N2A cells.
    Zhang L, Tetrault J, Wang W, Loh HH, Law PY.
    Mol Pharmacol; 2006 Jun 01; 69(6):1810-9. PubMed ID: 16525132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.